Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from NVO

3 Pharma Stock Buys You Don’t Want to Miss

The pharmaceutical industry is growing amid robust demand. Also, given that healthcare stocks are generally thought of as defensive investments, fundamentally strong Johnson & Johnson (JNJ), Novo Nordisk (NVO), and AstraZeneca (AZN) might be profitable buys now. Read on.

StockNews.com

3 July Pharma Picks for Profit

The pharma industry performs relatively well during downturns due to inelastic demand for its products and services. Therefore, fundamentally strong pharma stocks Novo Nordisk (NVO), AbbVie (ABBV), and Novartis (NVS) might be profitable buys. Read on.

StockNews.com

Diabetes Epidemic Makes this Stock a Strong Buy

Diabetes is a growing concern as more of the globe becomes modernized and with that is eating a diet that too often is a road to diabetes. Gladly there are drug companies at the forefront of this movement to stem the tide like Novo Nordisk (NVO) making it a very…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Tilray Brands (TLRY) vs. Novo Nordisk (NVO): Which Pharma Stock Should You Buy?

The pharmaceutical sector performs relatively well during economic uncertainties due to inelastic demand for its products and services. While prominent players Tilray Brands (TLRY) and Novo Nordisk (NVO) should benefit, which stock is the better buy now? Read more to find out.

StockNews.com

Why You Should Go Overweight On Novo Nordisk Stock

Novo Nordisk is already the global kingpin in diabetes treatments, with about 30% of the $50+ billion global diabetes market and around half of the $20 billion insulin therapy market. Now, it is becoming a powerhouse in weight-loss drugs, thanks to its Wegovy drug.

Barchart

3 Pharmaceutical Stocks to Watch

The pharmaceutical industry is anticipated to grow due to rising chronic diseases and an aging population. Given the industry's strong long-term prospects, quality stocks Novo Nordisk (NVO), Novartis (NVS), and Bristol-Myers Squibb (BMY) could be worth adding to your watchlist. Continue reading….

StockNews.com

3 Value Stocks to Add to Your Portfolio

The stock market will likely remain under pressure with rising concerns about an economic slump and high-interest rates. Therefore, investors could look to add fundamentally strong stocks Novo Nordisk (NVO), Novartis (NVS), and NetScout Systems (NTCT) to their portfolios, which are trading at discounts. Keep reading….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

2 Pharma Stocks Poised for Record-Breaking Growth

Due to innovative drug development and increasing demand for healthcare, the pharma industry is poised to thrive in the foreseeable future. Given the significant prospects of the industry, pharma stocks Novo Nordisk A/S (NVO) and Novartis AG (NVS) look poised for solid growth and might be ideal additions to one’s…

StockNews.com

Stay Forever Young With These 3 Pharmaceutical Stocks

Despite macroeconomic headwinds, the pharmaceutical industry is anticipated to stay buoyed in the foreseeable future, owing to rising healthcare spending. Against this backdrop, we think the strong fundamentals of Novo Nordisk (NVO), Bristol-Myers Squibb (BMY), and Takeda Pharmaceutical (TAK) make them wise portfolio additions. Read on….

StockNews.com

4 Medical Stocks That Could Help the Health of Investors’ Portfolios

The healthcare sector often fares well during difficult times due to the constant need for its goods and services. Therefore, quality medical stocks Novo Nordisk (NVO), AmerisourceBergen (ABC), Cardinal Health (CAH), and Haemonetics (HAE) might be the best investments for investors’ portfolios given current macroeconomic headwinds. Read on….

StockNews.com

3 No-Brainer Stocks to Buy Right Now

Amid the banking turmoil and the Fed’s latest quarter-point rate hike, the odds of a recession are back on the rise. Hence, it could be wise to invest in no-brainer stocks Taiwan Semiconductor Manufacturing (TSM), Novo Nordisk (NVO), and Merck & Co. (MRK) now. Read more….

StockNews.com

3 Stocks Every Investor Should Own

The Fed’s commitment to tame the sticky inflation is feared to trigger an economic slowdown in the near term. Amid such concerns, investors’ anxiety has been rising. Against this backdrop, quality stocks Novo Nordisk (NVO), Altria Group (MO), and Cardinal Health (CAH) might be owned by every trader at least…

StockNews.com

3 High-Quality Stocks to Buy Now and Hold for the Next Decade

With the Fed extremely likely to raise the benchmark interest rates higher than envisaged by policymakers, the economy and the stock market are expected to remain under pressure. Amid the uncertainty, it could be wise to invest in high-quality stocks Visa (V), Novo Nordisk A/S (NVO), and Autodesk (ADSK) for…

StockNews.com

1 Pharma Stock That Could Help You Become a Millionaire

Prominent pharma player Novo Nordisk (NVO) posted solid revenue and earnings growth in fiscal 2022. The company’s long-term growth is expected to be spearheaded by its immensely popular GLP-1 drug Wegovy. Given the potential of its current portfolio of drugs and drugs under research, investing in this stock could be…

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 High-Quality Stocks to Pick up in 2023

With slowing inflation, resilient economic growth, and a robust labor market aided by a slower rate hike by the Fed, fundamentally strong stocks Exxon Mobil (XOM), Novo Nordisk (NVO), and Bridgestone (BRDCY) seem to be good investments now. Continue reading….

StockNews.com

Best Stocks to Buy Right Now? 3 Large Caps to Watch this Week

Although inflation has cooled down over the past few months, the Fed intends to keep raising interest rates until inflation falls to its desired level. This is expected to push the economy into a recession. Investors looking to stabilize their portfolios against potential market volatility might look to add large-cap…

StockNews.com

3 High-Flying Pharma Stocks to Buy Right Now

The healthcare industry is poised to grow significantly in the coming years. Moreover, as healthcare stocks tend to perform relatively well despite macro uncertainties due to inelastic demand for their products and services, high-flying pharma stocks Novo Nordisk (NVO), AbbVie (ABBV), and Merck & Co (MRK) might be ideal investments…

StockNews.com

5 “Strong Buy” Health Care Stocks to Buy This Week

Rising prevalence of chronic diseases and the increasing aging population are significant growth drivers of the healthcare industry. Moreover, growing investments in technological advancements should bode well for the industry. Thus, we think investing in quality healthcare stocks Johnson & Johnson (JNJ), Pfizer (PFE), Novo Nordisk (NVO), Bristol-Myers Squibb (BMY),…

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Stocks to Buy That Won’t Give You Any Headaches

The stock market has witnessed significant volatility amid the record high inflation and the Fed’s hawkish stance on it. Investors have been banking on healthcare stocks as they tend to hold up relatively well in such turbulent times. We think investing in quality healthcare stocks Johnson & Johnson (JNJ), Pfizer…

StockNews.com

5 “Strong Buy” Stocks to Buy This Week

The Fed’s hawkish stance on inflation, along with other macroeconomic issues, has created substantial market volatility. However, it might be better to stay invested to reap long-term returns. To that end, fundamentally sound stocks Novo Nordisk (NVO), Centene (CNC), McKesson (MCK), Universal Logistics (ULH), and Sisecam Resources (SIRE) might be…

StockNews.com

3 Stocks No One Is Talking About but Should Be

Amid an uncertain market, it becomes increasingly difficult for investors to find stocks that can survive the challenges and deliver solid returns. Accel Entertainment (ACEL), Novo Nordisk (NVO), and Titan Machinery (TITN) are currently not on investors’ radar, but it could be worth adding these stocks to one’s portfolio given…

Benzinga

Here's How Much $1000 Invested In Novo Nordisk 5 Years Ago Would Be Worth Today

Novo Nordisk (NYSE:NVO) has outperformed the market over the past 5 years by 12.09% on an annualized basis producing an average annual return of 21.31%. Currently, Novo Nordisk has a market capitalization of $251.98 billion.

StockNews.com

5 "Strong Buy" Pharmaceutical Stocks to Own for the Long Haul

The inelastic demand and rising investments in research and development should drive the pharmaceutical industry’s growth in the long run. Therefore, pharmaceutical stocks AbbVie (ABBV), Amgen (AMGN), Catalyst (CPRX), Novo Nordisk (NVO), and Vertex (VRTX), which possess sound fundamentals, could be solid long-term investments. These stocks are rated Strong Buy…

Benzinga

If You Invested $100 In This Stock 10 Years Ago, You Would Have $400 Today

Novo Nordisk (NYSE:NVO) has outperformed the market over the past 10 years by 3.35% on an annualized basis producing an average annual return of 14.11%. Currently, Novo Nordisk has a market capitalization of $238.19 billion.

StockNews.com

3 High-Quality Large-Cap Stocks to Buy This Month

The better-than-expected May employment report indicates that the Federal Reserve will continue to raise interest rates aggressively this year. Since the fears of an economic slowdown are expected to keep the stock market extremely volatile, it could be wise to bet on high-quality large-cap stocks McKesson (MCK), Novo Nordisk (NVO),…

1 … 3 4 5 6

People

Dipanjan BanchurSince

722 stories

Steve Reitmeister

508 stories

Sristi Suman Jayaswal

90 stories

Lars Fruergaard Jørgensen

18 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.